ArticleKidney3602026

Bevacizumab-Associated Renal Adverse Events Signal Better Prognosis in Ovarian Cancer: A Double-Edged Vascular Endothelial Growth Factor Inhibition.

Cristina Riaza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.